0      0

53rd National Symposium 2022

270b - Symposium - The Integral Role of Nephrology Nurses in the Management of Hyperkalemia (Supported through an educational grant from AstraZeneca Pharmaceuticals)


May 24, 2022 7:30pm ‐ May 24, 2022 8:45pm



Credits: None available.

Members: $30.00
Standard: $40.00

Description

*Note: Limited to 100 people.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 5/25/2024.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

There are no Planning Committee disclosures to declare.

Speaker Disclosures:
Debra Castner, APN-C, CNN is on the Speakers Bureau for AstraZeneca and a past consultant for Cara Therapeutics.

Csaba P. Kovesdy, MD receives royalties from UpToDate and Springer and is a Consultant for Abbott, Akebia, AstraZeneca, Bayer, Boehringer-Ingelheim, CSL Behring, Cara Therapeutics, Rockwell, and Vifor.

Mary Schira, PhD, APRN, ACNP-BC is a speaker for the Baxter Peer Program and invited participant of VoxMedia Hyperkalemia Program at 2022 Symposium.

There are no other speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the care and management of CKD patients with hyperkalemia.

Speaker(s):

Credits Available


Symposium - The Integral Role of Nephrology Nurses in the Management of Hyperkalemia (Supported through an educational grant from AstraZeneca Pharmaceuticals)

You must be logged in and own this session in order to post comments.